High prevalence of [beta]-lactam and fluoroquinolone resistance in various phylotypes of Escherichia coli isolates from urinary tract infections in Jiroft city, Iran
Urinary tract infection (UTI) is one of the most prevalent infectious diseases with worldwide health threatening. Antimicrobial resistant strains of Escherichia coli (E. coli) are a common cause of UTI which were identified as a treatment challenge. This study aimed to assay the prevalence of common...
Gespeichert in:
Veröffentlicht in: | BMC microbiology 2023-04, Vol.23 (1) |
---|---|
Hauptverfasser: | , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | |
---|---|
container_issue | 1 |
container_start_page | |
container_title | BMC microbiology |
container_volume | 23 |
creator | Afsharikhah, Saleh Ghanbarpour, Reza Mohseni, Parvin Adib, Nasrin Bagheri, Mahboube Jajarmi, Maziar |
description | Urinary tract infection (UTI) is one of the most prevalent infectious diseases with worldwide health threatening. Antimicrobial resistant strains of Escherichia coli (E. coli) are a common cause of UTI which were identified as a treatment challenge. This study aimed to assay the prevalence of common [beta]-lactam resistance genes including bla.sub.TEM, bla.sub.SHV, bla.sub.CTX-M and bla.sub.CMY and phenotypic resistance to commonly used [beta]-lactam and fluoroquinolone antibiotics in UTIs. These factors were evaluated in various phylogenetic groups (phylotypes) of E. coli isolates. Real-time PCR was applied to detect [beta]-lactam resistance genes and conventional PCR was used to determine the phylotypes. Phenotypic resistance against [beta]-lactams (ceftazidime, cefotaxime, aztreonam and ceftriaxone) and fluoroquinolones (ciprofloxacin) were identified by the disc diffusion technique. The ability of extended spectrum [beta]-lactamases (ESBLs) production in E. coli isolates was detected using the combined disc diffusion method. The prevalence of resistance genes were 89.6% for bla.sub.TEM, 44.3% for bla.sub.CTX-M, 6.6% for bla.sub.SHV and 0.9% for bla.sub.CMY. The two high prevalent phylotypes were B2 (29.2%) and D (17.9%) followed by E (14.1%), F (9.4%), C (6.6%) and 10.3% of isolates were unknown in phylotyping. Disc diffusion results showed high prevalence of antibiotic resistance to cefotaxime (88.6%), aztreonam (83%), ceftireaxon (77.3%), ceftazidime (76.4%) and ciprofloxacin (55.6%). Totally, 52.8% of isolates were found as phenotypical ESBL-producers. This study's results confirmed an explosion of antibiotic resistance amongst E. coli isolates from UTI against [beta]-lactams and fluoroquinolones. Findings explain the necessity of deep changes in quantity and quality of drug resistance diagnosis and antibiotic therapy strategies. More studies are suggested to better and confident evaluations. |
doi_str_mv | 10.1186/s12866-023-02860-7 |
format | Article |
fullrecord | <record><control><sourceid>gale</sourceid><recordid>TN_cdi_gale_infotracmisc_A746669836</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A746669836</galeid><sourcerecordid>A746669836</sourcerecordid><originalsourceid>FETCH-LOGICAL-g1016-eb9018434ff70d639f48d8a247284e2213f041f9af87b65d09021c880e971c7b3</originalsourceid><addsrcrecordid>eNptkN9LwzAQx4soOKf_gE8BnwQ7kzQm6eMY6iYDwR9PIiNNkzbSNTNJh_2D_D9N0YcN5DjuuPvc945LknMEJwhxeu0R5pSmEGfROYUpO0hGiDCUYsTh4U5-nJx4_wEhYjxjo-R7bqoabJzaika1UgGrwVuhgnhPGyGDWAPRlkA3nXX2szOtbWyrgFPe-CAG3rRgK5yxnQebum9s6DfKDyq3XtbKGVkbAaRtDDDeNiLEpnZ2DTpnWuF6EFxcE1W0ksHY1g-CD8ZZHYA0ob8CCyfa0-RIi8ars784Tl7vbl9m83T5eL-YTZdphSCiqSpyiDjJiNYMljTLNeElF5gwzInCGGUaEqRzoTkr6E0Jc4iR5ByqnCHJimycXPzqVvEbq3iUHc5bGy9XU0YopTnPaKQm_1DRSrU2Mv5Hm1jfG7jcG4hMUF-hEp33q8Xz0y77AxM7jl8</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>High prevalence of [beta]-lactam and fluoroquinolone resistance in various phylotypes of Escherichia coli isolates from urinary tract infections in Jiroft city, Iran</title><source>DOAJ Directory of Open Access Journals</source><source>SpringerLink Journals</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central</source><source>PubMed Central Open Access</source><source>Springer Nature OA Free Journals</source><creator>Afsharikhah, Saleh ; Ghanbarpour, Reza ; Mohseni, Parvin ; Adib, Nasrin ; Bagheri, Mahboube ; Jajarmi, Maziar</creator><creatorcontrib>Afsharikhah, Saleh ; Ghanbarpour, Reza ; Mohseni, Parvin ; Adib, Nasrin ; Bagheri, Mahboube ; Jajarmi, Maziar</creatorcontrib><description>Urinary tract infection (UTI) is one of the most prevalent infectious diseases with worldwide health threatening. Antimicrobial resistant strains of Escherichia coli (E. coli) are a common cause of UTI which were identified as a treatment challenge. This study aimed to assay the prevalence of common [beta]-lactam resistance genes including bla.sub.TEM, bla.sub.SHV, bla.sub.CTX-M and bla.sub.CMY and phenotypic resistance to commonly used [beta]-lactam and fluoroquinolone antibiotics in UTIs. These factors were evaluated in various phylogenetic groups (phylotypes) of E. coli isolates. Real-time PCR was applied to detect [beta]-lactam resistance genes and conventional PCR was used to determine the phylotypes. Phenotypic resistance against [beta]-lactams (ceftazidime, cefotaxime, aztreonam and ceftriaxone) and fluoroquinolones (ciprofloxacin) were identified by the disc diffusion technique. The ability of extended spectrum [beta]-lactamases (ESBLs) production in E. coli isolates was detected using the combined disc diffusion method. The prevalence of resistance genes were 89.6% for bla.sub.TEM, 44.3% for bla.sub.CTX-M, 6.6% for bla.sub.SHV and 0.9% for bla.sub.CMY. The two high prevalent phylotypes were B2 (29.2%) and D (17.9%) followed by E (14.1%), F (9.4%), C (6.6%) and 10.3% of isolates were unknown in phylotyping. Disc diffusion results showed high prevalence of antibiotic resistance to cefotaxime (88.6%), aztreonam (83%), ceftireaxon (77.3%), ceftazidime (76.4%) and ciprofloxacin (55.6%). Totally, 52.8% of isolates were found as phenotypical ESBL-producers. This study's results confirmed an explosion of antibiotic resistance amongst E. coli isolates from UTI against [beta]-lactams and fluoroquinolones. Findings explain the necessity of deep changes in quantity and quality of drug resistance diagnosis and antibiotic therapy strategies. More studies are suggested to better and confident evaluations.</description><identifier>ISSN: 1471-2180</identifier><identifier>EISSN: 1471-2180</identifier><identifier>DOI: 10.1186/s12866-023-02860-7</identifier><language>eng</language><publisher>BioMed Central Ltd</publisher><subject>Beta lactamases ; Causes of ; Ciprofloxacin ; Communicable diseases ; Drug resistance in microorganisms ; Drug therapy ; Escherichia coli ; Genetic aspects ; Identification and classification ; Phylogeny ; Risk factors ; Statistics ; Urinary tract infections</subject><ispartof>BMC microbiology, 2023-04, Vol.23 (1)</ispartof><rights>COPYRIGHT 2023 BioMed Central Ltd.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,860,27901,27902</link.rule.ids></links><search><creatorcontrib>Afsharikhah, Saleh</creatorcontrib><creatorcontrib>Ghanbarpour, Reza</creatorcontrib><creatorcontrib>Mohseni, Parvin</creatorcontrib><creatorcontrib>Adib, Nasrin</creatorcontrib><creatorcontrib>Bagheri, Mahboube</creatorcontrib><creatorcontrib>Jajarmi, Maziar</creatorcontrib><title>High prevalence of [beta]-lactam and fluoroquinolone resistance in various phylotypes of Escherichia coli isolates from urinary tract infections in Jiroft city, Iran</title><title>BMC microbiology</title><description>Urinary tract infection (UTI) is one of the most prevalent infectious diseases with worldwide health threatening. Antimicrobial resistant strains of Escherichia coli (E. coli) are a common cause of UTI which were identified as a treatment challenge. This study aimed to assay the prevalence of common [beta]-lactam resistance genes including bla.sub.TEM, bla.sub.SHV, bla.sub.CTX-M and bla.sub.CMY and phenotypic resistance to commonly used [beta]-lactam and fluoroquinolone antibiotics in UTIs. These factors were evaluated in various phylogenetic groups (phylotypes) of E. coli isolates. Real-time PCR was applied to detect [beta]-lactam resistance genes and conventional PCR was used to determine the phylotypes. Phenotypic resistance against [beta]-lactams (ceftazidime, cefotaxime, aztreonam and ceftriaxone) and fluoroquinolones (ciprofloxacin) were identified by the disc diffusion technique. The ability of extended spectrum [beta]-lactamases (ESBLs) production in E. coli isolates was detected using the combined disc diffusion method. The prevalence of resistance genes were 89.6% for bla.sub.TEM, 44.3% for bla.sub.CTX-M, 6.6% for bla.sub.SHV and 0.9% for bla.sub.CMY. The two high prevalent phylotypes were B2 (29.2%) and D (17.9%) followed by E (14.1%), F (9.4%), C (6.6%) and 10.3% of isolates were unknown in phylotyping. Disc diffusion results showed high prevalence of antibiotic resistance to cefotaxime (88.6%), aztreonam (83%), ceftireaxon (77.3%), ceftazidime (76.4%) and ciprofloxacin (55.6%). Totally, 52.8% of isolates were found as phenotypical ESBL-producers. This study's results confirmed an explosion of antibiotic resistance amongst E. coli isolates from UTI against [beta]-lactams and fluoroquinolones. Findings explain the necessity of deep changes in quantity and quality of drug resistance diagnosis and antibiotic therapy strategies. More studies are suggested to better and confident evaluations.</description><subject>Beta lactamases</subject><subject>Causes of</subject><subject>Ciprofloxacin</subject><subject>Communicable diseases</subject><subject>Drug resistance in microorganisms</subject><subject>Drug therapy</subject><subject>Escherichia coli</subject><subject>Genetic aspects</subject><subject>Identification and classification</subject><subject>Phylogeny</subject><subject>Risk factors</subject><subject>Statistics</subject><subject>Urinary tract infections</subject><issn>1471-2180</issn><issn>1471-2180</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><recordid>eNptkN9LwzAQx4soOKf_gE8BnwQ7kzQm6eMY6iYDwR9PIiNNkzbSNTNJh_2D_D9N0YcN5DjuuPvc945LknMEJwhxeu0R5pSmEGfROYUpO0hGiDCUYsTh4U5-nJx4_wEhYjxjo-R7bqoabJzaika1UgGrwVuhgnhPGyGDWAPRlkA3nXX2szOtbWyrgFPe-CAG3rRgK5yxnQebum9s6DfKDyq3XtbKGVkbAaRtDDDeNiLEpnZ2DTpnWuF6EFxcE1W0ksHY1g-CD8ZZHYA0ob8CCyfa0-RIi8ars784Tl7vbl9m83T5eL-YTZdphSCiqSpyiDjJiNYMljTLNeElF5gwzInCGGUaEqRzoTkr6E0Jc4iR5ByqnCHJimycXPzqVvEbq3iUHc5bGy9XU0YopTnPaKQm_1DRSrU2Mv5Hm1jfG7jcG4hMUF-hEp33q8Xz0y77AxM7jl8</recordid><startdate>20230422</startdate><enddate>20230422</enddate><creator>Afsharikhah, Saleh</creator><creator>Ghanbarpour, Reza</creator><creator>Mohseni, Parvin</creator><creator>Adib, Nasrin</creator><creator>Bagheri, Mahboube</creator><creator>Jajarmi, Maziar</creator><general>BioMed Central Ltd</general><scope>ISR</scope></search><sort><creationdate>20230422</creationdate><title>High prevalence of [beta]-lactam and fluoroquinolone resistance in various phylotypes of Escherichia coli isolates from urinary tract infections in Jiroft city, Iran</title><author>Afsharikhah, Saleh ; Ghanbarpour, Reza ; Mohseni, Parvin ; Adib, Nasrin ; Bagheri, Mahboube ; Jajarmi, Maziar</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-g1016-eb9018434ff70d639f48d8a247284e2213f041f9af87b65d09021c880e971c7b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Beta lactamases</topic><topic>Causes of</topic><topic>Ciprofloxacin</topic><topic>Communicable diseases</topic><topic>Drug resistance in microorganisms</topic><topic>Drug therapy</topic><topic>Escherichia coli</topic><topic>Genetic aspects</topic><topic>Identification and classification</topic><topic>Phylogeny</topic><topic>Risk factors</topic><topic>Statistics</topic><topic>Urinary tract infections</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Afsharikhah, Saleh</creatorcontrib><creatorcontrib>Ghanbarpour, Reza</creatorcontrib><creatorcontrib>Mohseni, Parvin</creatorcontrib><creatorcontrib>Adib, Nasrin</creatorcontrib><creatorcontrib>Bagheri, Mahboube</creatorcontrib><creatorcontrib>Jajarmi, Maziar</creatorcontrib><collection>Gale In Context: Science</collection><jtitle>BMC microbiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Afsharikhah, Saleh</au><au>Ghanbarpour, Reza</au><au>Mohseni, Parvin</au><au>Adib, Nasrin</au><au>Bagheri, Mahboube</au><au>Jajarmi, Maziar</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>High prevalence of [beta]-lactam and fluoroquinolone resistance in various phylotypes of Escherichia coli isolates from urinary tract infections in Jiroft city, Iran</atitle><jtitle>BMC microbiology</jtitle><date>2023-04-22</date><risdate>2023</risdate><volume>23</volume><issue>1</issue><issn>1471-2180</issn><eissn>1471-2180</eissn><abstract>Urinary tract infection (UTI) is one of the most prevalent infectious diseases with worldwide health threatening. Antimicrobial resistant strains of Escherichia coli (E. coli) are a common cause of UTI which were identified as a treatment challenge. This study aimed to assay the prevalence of common [beta]-lactam resistance genes including bla.sub.TEM, bla.sub.SHV, bla.sub.CTX-M and bla.sub.CMY and phenotypic resistance to commonly used [beta]-lactam and fluoroquinolone antibiotics in UTIs. These factors were evaluated in various phylogenetic groups (phylotypes) of E. coli isolates. Real-time PCR was applied to detect [beta]-lactam resistance genes and conventional PCR was used to determine the phylotypes. Phenotypic resistance against [beta]-lactams (ceftazidime, cefotaxime, aztreonam and ceftriaxone) and fluoroquinolones (ciprofloxacin) were identified by the disc diffusion technique. The ability of extended spectrum [beta]-lactamases (ESBLs) production in E. coli isolates was detected using the combined disc diffusion method. The prevalence of resistance genes were 89.6% for bla.sub.TEM, 44.3% for bla.sub.CTX-M, 6.6% for bla.sub.SHV and 0.9% for bla.sub.CMY. The two high prevalent phylotypes were B2 (29.2%) and D (17.9%) followed by E (14.1%), F (9.4%), C (6.6%) and 10.3% of isolates were unknown in phylotyping. Disc diffusion results showed high prevalence of antibiotic resistance to cefotaxime (88.6%), aztreonam (83%), ceftireaxon (77.3%), ceftazidime (76.4%) and ciprofloxacin (55.6%). Totally, 52.8% of isolates were found as phenotypical ESBL-producers. This study's results confirmed an explosion of antibiotic resistance amongst E. coli isolates from UTI against [beta]-lactams and fluoroquinolones. Findings explain the necessity of deep changes in quantity and quality of drug resistance diagnosis and antibiotic therapy strategies. More studies are suggested to better and confident evaluations.</abstract><pub>BioMed Central Ltd</pub><doi>10.1186/s12866-023-02860-7</doi></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1471-2180 |
ispartof | BMC microbiology, 2023-04, Vol.23 (1) |
issn | 1471-2180 1471-2180 |
language | eng |
recordid | cdi_gale_infotracmisc_A746669836 |
source | DOAJ Directory of Open Access Journals; SpringerLink Journals; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central; PubMed Central Open Access; Springer Nature OA Free Journals |
subjects | Beta lactamases Causes of Ciprofloxacin Communicable diseases Drug resistance in microorganisms Drug therapy Escherichia coli Genetic aspects Identification and classification Phylogeny Risk factors Statistics Urinary tract infections |
title | High prevalence of [beta]-lactam and fluoroquinolone resistance in various phylotypes of Escherichia coli isolates from urinary tract infections in Jiroft city, Iran |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-31T09%3A49%3A08IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=High%20prevalence%20of%20%5Bbeta%5D-lactam%20and%20fluoroquinolone%20resistance%20in%20various%20phylotypes%20of%20Escherichia%20coli%20isolates%20from%20urinary%20tract%20infections%20in%20Jiroft%20city,%20Iran&rft.jtitle=BMC%20microbiology&rft.au=Afsharikhah,%20Saleh&rft.date=2023-04-22&rft.volume=23&rft.issue=1&rft.issn=1471-2180&rft.eissn=1471-2180&rft_id=info:doi/10.1186/s12866-023-02860-7&rft_dat=%3Cgale%3EA746669836%3C/gale%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rft_galeid=A746669836&rfr_iscdi=true |